FDA Deploys Agency-Wide AI Tool to Accelerate Scientific Reviews

1 min read
Source: Axios
FDA Deploys Agency-Wide AI Tool to Accelerate Scientific Reviews
Photo: Axios
TL;DR

The FDA has launched an agencywide generative AI tool called Elsa to streamline scientific reviews, support drug safety assessments, and improve efficiency, while emphasizing secure data handling within Amazon Web Services' GovCloud environment. Concerns remain about data security and the speed of AI integration into the agency's workflow.

Share this article

Want the full story? Read the original reporting

Read on Axios